Sun Pharma Advanced Research Company on Saturday reported a net loss of Rs. 2.51 crore for the first quarter ended March 31, 2014, mainly on account of increase in expenses during the period.
The company had posted a net profit of Rs. 44.04 crore during the same period of previous fiscal, Sun Pharma Advanced Research Company Ltd. (SPARC) said in a statement.
The total income of the company declined to Rs. 42.57 crore during the first quarter, as compared to Rs. 71.83 crore in the same period of previous fiscal.
ADVERTISEMENT
The company’s expenses during the quarter rose by 78.43 per cent to Rs. 48.16 crore in the first quarter, as against Rs. 26.99 crore during the same period of previous fiscal.
SPARC was demerged from Sun Pharmaceutical Industries Ltd as a research and drug discovery company in 2007.